Chiara Ambrogio

5.1k total citations · 1 hit paper
73 papers, 3.0k citations indexed

About

Chiara Ambrogio is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chiara Ambrogio has authored 73 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 25 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Chiara Ambrogio's work include Lung Cancer Treatments and Mutations (23 papers), Melanoma and MAPK Pathways (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Chiara Ambrogio is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Melanoma and MAPK Pathways (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Chiara Ambrogio collaborates with scholars based in United States, Italy and Spain. Chiara Ambrogio's co-authors include Roberto Chiarle, Claudia Voena, Giorgio Inghirami, Roberto Piva, David Santamarı́a, Cinzia Martinengo, Mariano Barbacid, Taek-Chin Cheong, Pasi A. Jänne and Rafael B. Blasco and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Chiara Ambrogio

72 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anaplastic lymphoma kinase in the pathogenesis of cancer

2007 643 citations Roberto Chiarle, Claudia Voena et al. Nature reviews. Cancer profile →

Peers

Chiara Ambrogio

ONCOL

PRM

PFM

Arnulfo Mendoza United States

Deric L. Wheeler United States

Sauveur-Michel Maira Switzerland

Rajeev Vibhakar United States

John Zevenhoven Netherlands

Frank Bartel Germany

Nathalie Dhomen United Kingdom

David Gentien France

Carrie Sougnez United States

James E. Korkola United States

Arnulfo Mendoza United States

Chiara Ambrogio

1.5k ×0.8

965 ×1.0

ONCOL

789 ×1.0

PRM

210 ×0.3

PFM

636 ×1.4

Citations per year, relative to Chiara Ambrogio Chiara Ambrogio (= 1×) peers Arnulfo Mendoza

Countries citing papers authored by Chiara Ambrogio

Since Specialization

Citations

This map shows the geographic impact of Chiara Ambrogio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Ambrogio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Ambrogio more than expected).

Fields of papers citing papers by Chiara Ambrogio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Ambrogio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Ambrogio. The network helps show where Chiara Ambrogio may publish in the future.

Co-authorship network of co-authors of Chiara Ambrogio

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Ambrogio. A scholar is included among the top collaborators of Chiara Ambrogio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Ambrogio. Chiara Ambrogio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voena, Claudia, Chiara Ambrogio, Fabio Iannelli, & Roberto Chiarle. (2025). ALK in cancer: from function to therapeutic targeting. Nature reviews. Cancer. 25(5). 359–378. 6 indexed citations

Novello, Silvia, et al.. (2024). Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node. Molecular Oncology. 18(6). 1355–1377. 8 indexed citations

Zhou, Zhiwei, Christel Poujol, Andreas Plückthun, et al.. (2024). Experimental variables determine the outcome of RAS-RAS interactions. Journal of Biological Chemistry. 300(11). 107859–107859. 4 indexed citations

Fernández‐Rodríguez, Ana, Coral Fustero‐Torre, Elena Piñeiro-Yáñez, et al.. (2024). Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors. Proceedings of the National Academy of Sciences. 121(36). e2402913121–e2402913121. 9 indexed citations

Alcolea, Maria P., Direna Alonso‐Curbelo, Chiara Ambrogio, et al.. (2024). Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discovery. 14(4). 674–682. 7 indexed citations

Menotti, Matteo, Cinzia Martinengo, Chiara Ambrogio, et al.. (2023). Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma. Frontiers in Oncology. 12. 2 indexed citations

Mecca, Carmen, Qi Wang, Chiara Ambrogio, et al.. (2021). Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood. 139(5). 717–731. 27 indexed citations

Costamagna, Andrea, Paola Cappello, Francesco Novelli, et al.. (2021). Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis. Gastroenterology. 162(4). 1242–1255.e11. 4 indexed citations

Mysore, Venkatesh, Zhi-Wei Zhou, Chiara Ambrogio, et al.. (2021). A structural model of a Ras–Raf signalosome. Nature Structural & Molecular Biology. 28(10). 847–857. 44 indexed citations

10.

Zhou, Zhi-Wei, Chiara Ambrogio, Asim K. Bera, et al.. (2020). KRASQ61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer. Cancer Research. 80(17). 3719–3731. 33 indexed citations

11.

Ambrogio, Chiara. (2020). IA02 Insights into KRAS Biology to Identify Potential Therapeutic Strategies. Journal of Thoracic Oncology. 15(2). S2–S2. 1 indexed citations

12.

Wang, Haiyun, Qi Lv, Yue Xu, et al.. (2019). An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. 49. 106–117. 21 indexed citations

13.

Dagogo‐Jack, Ibiayi, Pablo Martínez, Beow Y. Yeap, et al.. (2018). Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer. Clinical Cancer Research. 25(1). 158–165. 80 indexed citations

14.

Ambrogio, Chiara, Élodie Darbo, Sam W. Lee, & David Santamarı́a. (2018). A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance. Cell Adhesion & Migration. 12(4). 1–4. 8 indexed citations

15.

Choudhari, Ramesh, Valerio Giacomo Minero, Matteo Menotti, et al.. (2016). Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice. Blood. 127(10). 1297–1306. 20 indexed citations

16.

Ambrogio, Chiara, Francisco javier García Carmona, August Vidal, et al.. (2014). Modeling Lung Cancer Evolution and Preclinical Response by Orthotopic Mouse Allografts. Cancer Research. 74(21). 5978–5988. 18 indexed citations

17.

Boselli, Daniela, Josiane Ragimbeau, Luca Orlando, et al.. (2010). Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes. Immunology Letters. 134(1). 17–25. 12 indexed citations

18.

Ambrogio, Chiara, Cinzia Martinengo, Claudia Voena, et al.. (2009). NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells. Cancer Research. 69(22). 8611–8619. 71 indexed citations

19.

Ambrogio, Chiara, Claudia Voena, Andrea D. Manazza, et al.. (2008). The Anaplastic Lymphoma Kinase Controls Cell Shape and Growth of Anaplastic Large Cell Lymphoma through Cdc42 Activation. Cancer Research. 68(21). 8899–8907. 41 indexed citations

20.

Voena, Claudia, Chiara Conte, Chiara Ambrogio, et al.. (2007). The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. Cancer Research. 67(9). 4278–4286. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact